NCT02914353View on ClinicalTrials.gov

Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Arthroplasty, Replacement, Knee
Interventions
DRUG

EP=7041

Factor X!a Inhibitor

DRUG

Placebo

Normal Saline

Trial Locations (1)

Unknown

IDT CMAX, Adelaide

Sponsors
All Listed Sponsors
collaborator

IDT CMAX Clinical Trials

UNKNOWN

collaborator

Syneos Health

OTHER

collaborator

CPR Pharma Services Pty Ltd, Australia

INDUSTRY

lead

eXIthera Pharmaceuticals

INDUSTRY